A Study to Describe Pediatric Influenza Vaccine Coverage

This study has been completed.
Sponsor:
Information provided by:
MedImmune LLC
ClinicalTrials.gov Identifier:
NCT00639418
First received: March 4, 2008
Last updated: November 4, 2011
Last verified: November 2011
  Purpose

The purpose of this study is to describe influenza vaccine coverage in children less than 18 years of age and to examine correlations between in-office influenza vaccine coverage various tactics to increase vaccine coverage.


Condition
Healthy

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: An Observational Study to Describe Pediatric Influenza Vaccine Coverage Among Pediatricians in the U.S.

Resource links provided by NLM:


Further study details as provided by MedImmune LLC:

Primary Outcome Measures:
  • Influenza vaccine coverage in children <18 years of age by age group [ Time Frame: Seasonal: 2007-2011 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Compliance with the recommended two-dose regimen in vaccinated children [ Time Frame: Seasonal: 2007-2011 ] [ Designated as safety issue: No ]
  • Correlation of office vaccination-related attitudes and activities with actual vaccine coverage [ Time Frame: Seasonal: 2007-2011 ] [ Designated as safety issue: No ]

Estimated Enrollment: 0
Study Start Date: September 2007
Study Completion Date: July 2011
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Children 6 to 23 months
2
Children 24 to 59 months
3
Children 5 to 8 years
4
Children 9 to 17 years

Detailed Description:

To describe influenza vaccine coverage in children less than 18 years of age in practicing pediatricians' offices and family medicine physicians' offices and to examine correlations between in-office influenza vaccine coverage and the use of various tactics to increase vaccine coverage.

  Eligibility

Ages Eligible for Study:   6 Months to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Up to 100 pediatrician and family medicine physician offices will be selected to participate in the study.

Criteria

Inclusion Criteria:

  • 6 months to 17 years of age
  • Males and females

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00639418

  Show 187 Study Locations
Sponsors and Collaborators
MedImmune LLC
Investigators
Study Director: Seth Toback, M.D. MedImmune LLC
  More Information

Additional Information:
No publications provided

Responsible Party: Seth Toback, M.D., MedImmune, LLC
ClinicalTrials.gov Identifier: NCT00639418     History of Changes
Other Study ID Numbers: MI-MA156
Study First Received: March 4, 2008
Last Updated: November 4, 2011
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Influenza, Human
Orthomyxoviridae Infections
RNA Virus Infections
Virus Diseases
Respiratory Tract Infections
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on August 26, 2014